Ambu A/S (OTCMKTS:AMBBY) Shares Down 5%
Ambu A/S (OTCMKTS:AMBBY) Shares Down 5%
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.Ambu A/S (OTCMKTS:AMBBY – Get Rating)'s stock price was down 5% during trading on Monday . The stock traded as low as $9.63 and last traded at $9.63. Approximately 500 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 10,669 shares. The stock had previously closed at $10.14.
Ambu A/S(OTCMKTS：AMBBY-GET Rating)的股價在週一的交易中下跌了5%。該股最低交易價格為9.63美元，最新報9.63美元。午盤交易中，約有500股股票易手，較10,669股的日均成交量下降了95%。該股此前收盤報10.14美元。
Analysts Set New Price Targets
分析師設定新的價格目標
Separately, Danske lowered shares of Ambu A/S from a "buy" rating to a "hold" rating in a research note on Monday, May 9th.
另外，丹斯克在5月9日星期一的一份研究報告中將Ambu A/S的股票評級從“買入”下調至“持有”。
Ambu A/S Stock Down 5.0 %
Ambu A/S股票下跌5.0%
The firm's 50 day simple moving average is $10.18 and its 200 day simple moving average is $12.94.
該公司的50日簡單移動均線切入位為10.18美元，200日簡單移動均線切入位為12.94美元。
About Ambu A/S
關於Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S開發、生產醫療設備，並向世界各地的醫院、診所和救援服務銷售。它在可視化、麻醉以及患者監測和診斷領域提供醫療解決方案。該公司提供內窺鏡產品，如支氣管鏡和監護儀；以及神經學產品，包括EEG和EMG電極、EMG引導注射和術中監測產品。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Ambu A/S (AMBBY)
- What Does an Inverted Yield Curve Mean For You?
- SPY vs. QQQ: Which ETF Wins in 2022?
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- 免費獲取StockNews.com關於Ambu A/S的研究報告(AMBBY)
- 收益率曲線倒置對你意味着什麼？
- 標普500ETF VS QQQ：2022年哪隻ETF勝出？
- 隨着管理層重組，股市能否迅速反彈？
- MarketBeat：回顧中的一週8/29-9/2
- 霍梅爾在這些水平上看起來很便宜
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
接受Ambu A/S日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Ambu A/S和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
